{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-039135","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-08-19T12:30:25+00:00","discovered_at":"2026-08-19T12:35:00.845854+00:00","generated_at":"2026-08-19T12:35:09.894008+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aspire Biopharma distributes investor presentation; content not disclosed in 8-K","bullets":["Company intends to distribute an investor presentation dated August 19, 2026.","Presentation furnished as Exhibit 99.1; no financial figures in the 8-K body.","No specific operational or financial updates provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-039135","json":"https://secwatch.observer/filing/0001493152-26-039135.json","markdown":"https://secwatch.observer/filing/0001493152-26-039135.md","text":"https://secwatch.observer/filing/0001493152-26-039135.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226039135/0001493152-26-039135-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226039135/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-19T12:35:09.894008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}